drugset / Trial / NCT00185315

Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension

NCT00185315

Phase 3 Completed 71 enrolled Bayer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The aim of this study is to monitor long-term safety and tolerability of iloprost aerosol inhalation therapy in patients suffering from pulmonary hypertension.

Timeline

Start
2000-02
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Iloprost Other / unclassified Inhaled